Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731360) titled 'Non-Invasive Diagnostic Panel for MASLD in Children With Obesity' on July 22.

Study Type: Observational

Primary Sponsor: Kayseri City Hospital

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease Pediatric Obesity Insulin Resistance Syndrome

Intervention: Diagnostic Test: Non-Invasive Multi-Parameter Diagnostic Panel

Recruitment Status: Not recruiting

Date of First Enrollment: July 1, 2026

Target Sample Size: 180

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07731360

Disclaimer: Curated by HT Syndication....